funcbio

Approximately 20% of patients with non-small cell lung cancer (NSCLC) are diagnosed with stage III disease. There is currently no consensus on the most appropriate treatment for these patients.

From June 25 to 29, the 2023 National Leprosy Prevention and Control Management Information System Conference Training Course organized by the National Disease Control and Prevention Bureau and the Leprosy Control Center of the Chinese Center for Disease Control and Prevention was held in Yanji City, Jilin Province.

On June 21, 2023, Nature Reviews Drug Discovery published an article titled "Trends in the approval of cancer therapies by the FDA in the twenty-first century."

Recently, the monkeypox virus nucleic acid detection kit, a product independently developed by Suzhou Fangke Biotechnology Co., Ltd., a subsidiary of Baiyang Biodiagnostics, successfully obtained CE certification.

For patients with early-stage epidermal growth factor receptor mutation-positive (EGFR-M+) non-small cell lung cancer (NSCLC), adjuvant chemotherapy after radical surgery is considered the standard of care.

Recently, Suzhou FuncBiotechnology Co., Ltd., a subsidiary of Baiyang Biodiagnostics, announced that its independently developed BP180, BP230, JO-1, TIF1-γ, MDA5, etc.

Recently, the National Health Commission's Clinical Laboratory Center (NCCL) released the "2023 National Clinical Laboratory External Quality Evaluation Report". Qingdao Bodhi Huisheng Medical Testing Co., Ltd. (referred to as "Bodhi Testing"), a subsidiary of Baiyang Biodiagnostics, participated in the "Bioinformatics Analysis of High-throughput Sequencing Detection of Tumor Somatic Mutations" and passed the assessment with full marks.

Recently, Suzhou FuncBiotechnology Co., Ltd., a subsidiary of Baiyang Biodiagnostics, jointly developed two products with the Dermatology Hospital of the Chinese Academy of Medical Sciences (Institute of Dermatology, Chinese Academy of Medical Sciences) and the Leprosy Control Center of the Chinese Center for Disease Control and Prevention.